209 related articles for article (PubMed ID: 15701722)
1. Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.
Yasuda S; Morokawa N; Wong GW; Rossi A; Madhusudhan MS; Sali A; Askew YS; Adachi R; Silverman GA; Krilis SA; Stevens RL
Blood; 2005 May; 105(10):3893-901. PubMed ID: 15701722
[TBL] [Abstract][Full Text] [Related]
2. Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells.
Wong GW; Yasuda S; Madhusudhan MS; Li L; Yang Y; Krilis SA; Sali A; Stevens RL
J Biol Chem; 2001 Dec; 276(52):49169-82. PubMed ID: 11602603
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
[TBL] [Abstract][Full Text] [Related]
4. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
[TBL] [Abstract][Full Text] [Related]
5. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
[TBL] [Abstract][Full Text] [Related]
6. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition.
Hansen M; Wind T; Blouse GE; Christensen A; Petersen HH; Kjelgaard S; Mathiasen L; Holtet TL; Andreasen PA
J Biol Chem; 2005 Nov; 280(46):38424-37. PubMed ID: 16141208
[TBL] [Abstract][Full Text] [Related]
7. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H
Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of recombinant gamma-tryptase.
Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM
Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034
[TBL] [Abstract][Full Text] [Related]
9. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase).
Stack MS; Johnson DA
J Biol Chem; 1994 Apr; 269(13):9416-9. PubMed ID: 8144524
[TBL] [Abstract][Full Text] [Related]
10. Human/chicken urokinase chimeras demonstrate sequences outside the serine protease domain that dictate autoactivation.
Aimes RT; Regazzoni K; Quigley JP
Thromb Haemost; 2003 Feb; 89(2):382-92. PubMed ID: 12574820
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
12. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
Takeuchi T; Harris JL; Huang W; Yan KW; Coughlin SR; Craik CS
J Biol Chem; 2000 Aug; 275(34):26333-42. PubMed ID: 10831593
[TBL] [Abstract][Full Text] [Related]
13. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract][Full Text] [Related]
15. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
Sipley JD; Alexander DS; Testa JE; Quigley JP
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
[TBL] [Abstract][Full Text] [Related]
16. Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.
Beaufort N; Seweryn P; de Bentzmann S; Tang A; Kellermann J; Grebenchtchikov N; Schmitt M; Sommerhoff CP; Pidard D; Magdolen V
Biochem J; 2010 May; 428(3):473-82. PubMed ID: 20337595
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway.
Wong GW; Foster PS; Yasuda S; Qi JC; Mahalingam S; Mellor EA; Katsoulotos G; Li L; Boyce JA; Krilis SA; Stevens RL
J Biol Chem; 2002 Nov; 277(44):41906-15. PubMed ID: 12194977
[TBL] [Abstract][Full Text] [Related]
18. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase.
Kilpatrick LM; Harris RL; Owen KA; Bass R; Ghorayeb C; Bar-Or A; Ellis V
Blood; 2006 Oct; 108(8):2616-23. PubMed ID: 16794252
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the protease domain of urokinase-type plasminogen activator.
Rockway TW; Nienaber V; Giranda VL
Curr Pharm Des; 2002; 8(28):2541-58. PubMed ID: 12369939
[TBL] [Abstract][Full Text] [Related]
20. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Husain SS
Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
